As electromobility, renewable energy systems, and portable electronics continue to grow, the demand for efficient energy storage technologies is increasing rapidly. However, performance alone is no longer sufficient. The environmental footprint of batteries and supercapacitors is becoming a decisive factor. The future of energy storage must be not only powerful, but also sustainable, recyclable, and resource-efficient.

Preclinical Development of a Depot System for the Neurotherapeutic Peptide NX210c

Therapeutic peptides occupy a unique position in modern drug development. They combine high biological specificity with comparatively low toxicity and favorable tissue penetration. However, their clinical application is often limited by rapid in vivo degradation and short systemic half-life.

Modern wound care faces major challenges: both chronic and acute wounds require more than simple protection - they need targeted support of the body’s natural healing processes. Innovative delivery systems that combine bioactivity, biocompatibility and controlled release are therefore gaining increasing attention.

Antibiotic resistance is on the rise worldwide. Even well-established drugs are increasingly failing against dangerous pathogens such as MRSA, Klebsiella pneumoniae or Candida albicans. The development of novel antimicrobial systems is therefore more urgent than ever.